Replies to post #350802 on Anavex Life Sciences Corp (AVXL)

[samk]

IMHO, first indication of A2-73, RETT SYNDROM, will be approved very soon!
Why? Because of the following events in AVATAR trial:
- upgrading PH2 to PH3 (FDA wants to approve this drug ASAP, if all OK).
- meeting all primary and secondary end-points without any adverse side
effects.

Since there is no other treatment currently exists to treat RETT, the only logical decision by the FDA should be approval ASAP.
RETT Foundation will also play big role to accelerate this process, IMO.

And now we understand why it took so long to release results of AVATAR
results when it was PH2!
And remember how the FUD crew "predicted", that AVATAR results must be
bad and Dr. M is hiding it...

So, it is just a matter of a 'short' time to see the approval.

Congratulation LONGS!!!